Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Washington
Antengene Corporation
University of Miami
Gruppo Italiano Malattie EMatologiche dell'Adulto
Case Comprehensive Cancer Center
ADC Therapeutics S.A.
Hackensack Meridian Health
Pfizer
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Celgene
Fred Hutchinson Cancer Center
University of Nebraska
Philogen S.p.A.
University of Nebraska
University of Washington
MEI Pharma, Inc.
Hoffmann-La Roche
Rush University Medical Center
University Hospital Southampton NHS Foundation Trust
Spectrum Pharmaceuticals, Inc
Hoffmann-La Roche
Northwestern University
Fred Hutchinson Cancer Center
Pfizer
JHL Biotech, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Seagen Inc.
Vanderbilt-Ingram Cancer Center
Hoffmann-La Roche
Barbara Ann Karmanos Cancer Institute
Seagen Inc.
Pfizer
Lymphoma Study Association
Wake Forest University Health Sciences
Seagen Inc.
Ohio State University Comprehensive Cancer Center
Stanford University
City of Hope Medical Center
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
MedImmune LLC
University of Miami